Appendix 1—table 2. Mixed effects models on model-agnostic choice data from uncertainty trials.

Name	Estimate	SE	t-Stat	DF	p-Value	Lower CI	Upper CI
Preferential MFCA for the informative destination (ghost-nominated, ‘repeat trials’ > ghost-rejected, ‘switch trials’)MFCA ~ NOM*DRUG*ORDER + (NOM + DRUG + ORDER | PART)
(Intercept)	0.10	0.01	8.27	239	0.000	0.07	0.12
NOM (nomination)	0.03	0.02	1.57	239	0.117	–0.01	0.08
DRUG	0.01	0.02	0.40	239	0.687	–0.04	0.06
ORDER	0.00	0.02	0.13	239	0.895	–0.04	0.05
NOM*DRUG	0.11	0.04	2.73	239	0.007	0.03	0.19
NOM*ORDER	0.02	0.04	0.51	239	0.613	–0.06	0.10
DRUG*ORDER	–0.03	0.05	–0.73	239	0.467	–0.12	0.06
NOM*DRUG*ORDER	–0.01	0.09	–0.04	239	0.966	–0.18	0.17
MFCA for non-informative destination (ghost-nominated > ghost-rejected, ‘clash trials’)REPEAT ~ N*I*DRUG*ORDER + (N*I*DRUG + ORDER | PART)
(Intercept)	0.05	0.04	1.27	479	0.203	–0.03	0.12
N (non-informative)	0.13	0.07	1.96	479	0.051	0.00	0.26
I (informative)	1.01	0.10	9.95	479	0.000	0.81	1.21
DRUG	0.16	0.07	2.31	479	0.021	0.02	0.29
ORDER	0.03	0.07	0.41	479	0.684	–0.10	0.16
N*U	0.08	0.14	0.57	479	0.568	–0.19	0.35
N*DRUG	0.05	0.13	0.39	479	0.696	–0.21	0.31
I*DRUG	0.03	0.15	0.24	479	0.810	–0.25	0.32
N*ORDER	–0.05	0.13	–0.34	479	0.733	–0.30	0.21
I*ORDER	0.06	0.14	0.43	479	0.664	–0.22	0.35
DRUG*ORDER	–0.20	0.15	–1.37	479	0.171	–0.49	0.09
N*I*DRUG	0.07	0.29	0.26	479	0.798	–0.49	0.64
N*I*ORDER	0.25	0.29	0.86	479	0.388	–0.32	0.81
N*DRUG*ORDER	–0.47	0.26	–1.80	479	0.072	–0.99	0.04
I*DRUG*ORDER	–0.12	0.41	–0.31	479	0.759	–0.92	0.67
N*I*DRUG*ORDER	0.86	0.55	1.56	479	0.119	–0.22	1.94